Cancer and Metastasis Reviews

Papers
(The TQCC of Cancer and Metastasis Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer229
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities155
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms117
Clonal tracking in cancer and metastasis112
The functions and modifications of tRNA-derived small RNAs in cancer biology91
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective79
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression76
Obesity and cancer76
Regulation of dormancy during tumor dissemination: the role of the ECM71
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions58
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?55
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations52
CAR T-cell therapy to treat multiple myeloma: current state and future directions51
Targeting lipid metabolism in cancer: neuroblastoma50
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer50
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor48
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives48
A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients45
Cell-cell interactions mediating primary and metastatic breast cancer dormancy42
p73 isoforms meet evolution of metastasis41
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?40
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond39
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review37
Preface35
Biography—Mathieu Boissan, Pharm.D., Ph.D35
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance33
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer33
Neuropeptide Y in cancer—biological functions and potential clinical implications32
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy31
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance31
Biographies31
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications29
Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis29
Tumor necrosis factor superfamily signaling: life and death in cancer28
Short-chain fatty acids in cancer pathogenesis28
The role of cancer cell bioenergetics in dormancy and drug resistance28
Clusterin: a marker and mediator of chemoresistance in colorectal cancer27
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology27
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy26
Helicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development26
Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy25
Vaping and tumor metastasis: current insights and progress25
The emerging roles of histone demethylases in cancers25
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions25
Functional and clinical roles of stromal PDGF receptors in tumor biology25
Clinical interventions to break the obesity and cancer link: a narrative review25
Carcinoma of unknown primary (CUP): an update for histopathologists25
Kenneth V. Honn, Ph.D. (1946–2023)24
The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy24
Racial disparity in prostate cancer: an outlook in genetic and molecular landscape24
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution24
Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review24
OX40/OX40 ligand and its role in precision immune oncology24
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases23
UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect23
Inflammatory bowel disease and carcinogenesis23
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting22
New progress of tuberculosis scar carcinoma22
Ferroptosis: iron release mechanisms in the bioenergetic process22
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies22
Biographies21
Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective21
HOXA9 transcription factor is a double-edged sword: from development to cancer progression21
Is cancer an intelligent species?20
Multifaceted role of the DNA replication protein MCM10 in maintaining genome stability and its implication in human diseases20
3.5899159908295